Eiko Lifesciences has informed that as required under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 13th August, 2024 to consider and approve the following: The Unaudited Financial Results (Standalone & Consolidation basis) of the Company for the quarter ending on 30th June, 2024 in accordance with Regulation 33 of the SEBI Listing Regulation; Any other matter with the permission of the chair. Further, pursuant to the Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters, Designated Employees and Connected Persons of the Company and pursuant to SEBI (Prohibition of insider Trading) Regulations 2015, the Trading Window for dealing in securities of the Company for all the Designated Persons is already closed with effect from 01st July, 2024, which shall continue to remain closed for all the Designated Persons and their Immediate Relatives till 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ending on 30th June, 2024.
Company Name | CMP |
---|---|
Tata Chemicals | 1069.40 |
SRF | 2165.85 |
Pidilite Inds. | 2958.60 |
Aarti Inds | 430.80 |
Atul | 7261.00 |
View more.. |